The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
syntaxin | 26 |
toxogen | 1 |
allergan | 1 |
syntaxin limited, salisbury | 1 |
ipsen bioinnovation | 27 |
ipsen biopharm | 11 |
allergan | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
fusion proteins | 70 | 2004 |
suppression of neuroendocrine diseases | 42 | 2008 |
recombinant clostridium botulinum neurotoxins | 33 | 2012 |
methods for the manufacture of proteolytically processed polypeptides | 29 | 2012 |
suppression of cancer | 23 | 2008 |
fusion proteins and methods for treating, preventing or ameliorating pain | 23 | 2012 |
transport protein which is used to introduce chemical compounds into nerve cells | 23 | 2004 |
therapeutic fusion proteins | 21 | 2011 |
cationic neurotoxins | 19 | 2013 |
assay for assessment of endosomal transport | 19 | 2012 |